BJ

BioLife Solutions IncDUS BioLife Stock Report

Last reporting period 30 Jun, 2024

Updated 11 Nov, 2024

Last price

Market cap $B

1.144

Small

Exchange

XDUS - Boerse Duesseldorf

BJX1.DU Stock Analysis

BJ

Uncovered

BioLife Solutions Inc is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

-24/100

Low score

Market cap $B

1.144

Dividend yield

Shares outstanding

42.766 B

BioLife Solutions, Inc. engages in the development, manufacture and marketing of bio preservation tools for cells and tissues. The company is headquartered in Bothell, Washington. Its products are used in basic and applied research and commercial manufacturing of biologic-based therapies. The company has a portfolio of tools and services that focus on biopreservation, cell processing, frozen biologic storage products and services, cold-chain transportation, and thawing of biologic materials. Its tools portfolio includes its CryoStor and HypoThermosol biopreservation media for shipping and storage, the ThawSTAR family of automated, water-free thawing products, evo cold chain management system, high capacity cryogenic storage freezers, Stirling Ultracold mechanical freezers, SciSafe biologic storage services, and Sexton Biotechnologies cell processing tools. Customers use its products to maintain the health and function of biologic material during sourcing, manufacturing, storage, and distribution.

View Section: Eyestock Rating